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ABSTRACT 
Heaves is triggered by exposure to dust and its components, such as endotoxin, 
and is characterized by clinical signs such as coughing, decreased exercise tolerance, 
difficulty breathing and abnormal lung sounds which are due to bronchoconstriction and 
accumulation of neutrophils in the airways. Pulmonary intravascular macrophages (PIMs) 
are believed to increase horses’ sensitivity to endotoxemia-induced lung inflammation. 
The first objective of this study was to investigate a hitherto unknown role of PIMs in 
equine heaves. I used mouldy hay (MH) to induce heaves and gadolinium chloride (GC) 
to deplete PIMs in order to compare responses between non-treated and GC-treated 
heaves horses. A modified randomized crossover study (2X2 factorial) was conducted in 
which mares (N=9) were exposed to 4 different treatments: alfalfa cubes (Cb), alfalfa 
cubes + GC (Cb-GC), mouldy hay (MH) and MH + GC (MH-GC). Each treatment was 
followed by broncholaveolar lavage (BAL). MH was fed for 7 days to induce heaves 
followed by Cb for 21 days to achieve remission, whereas the treatments in which heaves 
was not induced (Cb; Cb-GC), the cubes were fed prior to the BAL and for 14 days after 
the BAL to allow recovery from the BAL procedure. BAL fluids were processed to 
investigate total cell, neutrophil and alveolar macrophage concentrations. In addition, 
TNFα protein levels as well as TNFα, IL-8, and TLR4 mRNA expression in BAL cells 
were assessed in order to infer on their activation state.  
Data showed higher concentration of dust (3X), endotoxin (20X), and endotoxin 
per milligram of dust (7X) in MH compared to the Cb environment. Clinical scores and 
neutrophil concentrations in BAL were higher when mares received MH compared to 
MH and GC (MH-GC). Real time reverse transcriptase PCR revealed a significant lower 
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expression of IL-8 and TLR4 mRNA in BAL cells from MH-GC mares compared to MH. 
TNFα mRNA expression as well as protein concentration were not affected by the 
different treatments. In vitro secondary LPS challenge significantly increased IL-8 
mRNA expression in cells from MH treatment compared to without LPS, but not in the 
MH-GC treatment. TLR4 expression was not affected by the secondary challenge. 
Although secondary LPS challenge increased expression of TNFα mRNA and protein, 
the differences among treatment groups were not meaningful. In conclusion, PIM 
depletion attenuates clinical scores, migration of inflammatory cells into the alveolar 
space and expression of pro-inflammatory molecules in BAL cells of heaves horses. 
The observations on the role of PIMs in heaves in horses prompted me to 
examine the occurrence of PIMs in human lungs. I found a trend for higher numbers of 
septal macrophages in autopsied lungs from human patients who died of non-pulmonary 
pathologies compared to those having either COPD or asthma. If these septal 
macrophages indeed represent the PIMs, this finding is contrary to existing belief that 
humans, unlike horses, do not have PIMs.  
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1. GENERAL INTRODUCTION 
1.1. Prevalence and significance in equine industry 
Heaves, Broken Wind, and recurrent airway obstruction (RAO) are  used to 
describe a chronic, reversible respiratory tract disease of horses characterized by 
coughing, mucopurulent discharge from both nostrils, dyspnea and exercise intolerance 
(McPherson et al. 1978; Robinson 2001; Couetil and Ward 2003; Leguillette 2003).  
Horses older than 7 years of age are most frequently affected, and the prevalence 
increases with age (Couetil and Ward 2003). In addition, a higher prevalence of heaves 
affected horses was observed in the Northern Hemisphere, where the horses are housed 
indoors in relatively humid climate, and hay is not adequately dried (Leguillette 2003).  
Heaves affects a horse’s breathing which impacts mobility. Hence, pleasure horses as 
well as sport horses are at risk. 
 
1.2. Aetiological factors 
Equine heaves resembles those human occupational lung diseases caused by 
inhaled organic dusts. The dust in the environment of a stabled horse is composed of 
more than 50 species of moulds, forage mites, endotoxins and inorganic components. The 
contribution of each of these components to the aetiology of heaves is unknown and 
perhaps some are synergistic in their pathogenicity (e.g. moulds and bacterial 
endotoxins). Other, non-specific environmental factors such as cold air and dry air may 
be important determinants of the day-to-day severity of pulmonary dysfunction 
(Robinson 2001).  
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Investigation of the risk factors for airway inflammation in pleasure horses in 
North America showed that the type of roughage being fed was a major determinant of 
the number of inflammatory cells in the trachea. Horses eating hay had more neutrophils 
in the trachea than horses on pasture. Within the hay-fed category, horses eating from 
round bales had more inflammatory cells than those eating from square bales. Pasture 
halved the risk for development of heaves compared to eating from square bales 
(Robinson et al. 2006). Hay varies greatly in its dust content, and concentrations of dust 
in the breathing zone can be over 20 mg/m3 of air when horses eat from square bales 
(Woods et al. 1993). Horses eating from round bales are likely to have even greater 
exposure to dust because they keep their faces immersed in the centre of the bale as they 
eat. Pasture generally provides little dust exposure because of its relatively high water 
content (Robinson et al. 2006). Changing horses’ feed from hay to haylage resulted in 
approximately a 60–70% reduction in mean respirable dust concentration, depending on 
bedding type. In comparison, changing bedding from straw to wood shavings results in 
approximately a 23–32% reduction in mean respirable dust concentration depending on 
feed type (Clements and Pirie 2007). 
 
1.3. Clinical signs 
Clinical signs of heaves are caused by the resistance to airflow in the lung due to 
diffused bronchoconstriction and mucus accumulation. A large number of constricted 
small bronchi are necessary to impede airflow throughout the lower parts of the lung to 
the point where clinical signs may appear. The bronchoconstriction is extended to all the 
lung parenchyma (Leguillette 2003).  Exercise intolerance is one of the main complaints 
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and it usually worsens slowly. The most striking clinical signs are cough, respiratory 
distress indicated by increased abdominal effort and nasal flaring, mucopurulent nasal 
discharge, abnormal lung and tracheal sounds and an enlarged lung percussion field 
(Dixon et al. 1995; Robinson 2001). Heaves-affected horses change their breathing 
pattern and typically have a rapid inspiration and a forced prolonged exhalation. When 
chronically affected, horses can show hypertrophy of the external abdominal oblique 
muscles, also called a “heave line” (Leguillette 2003).  However, lack of clinical signs or 
very mild clinical signs, such as occasional cough, or minimal abdominal effort, may 
render the diagnosis difficult. Rebreathing increases lung sounds, but ancillary diagnostic 
techniques often are required (Dixon et al. 1995; Robinson 2001). Exposure of 
susceptible horses to moulds may trigger the appearance of clinical signs within 5 h 
(Brazil et al. 2005) to 2 days (Tesarowski et al. 1996). When horses are put in a 
controlled environment or turned out to pasture clinical signs are reversible. Several 
studies reported an improvement of the respiratory function of heaves horses 1 week after 
being turned outside on pasture (Leguillette 2003).  Others showed remission of signs 
only after four to six weeks when put in controlled environment or pasture (McGorum et 
al. 1993a; Vandenput et al. 1998; Davis and Rush 2002).  Subjective clinical scores are 
used in research and are often based on nasal flaring, abdominal effort, and auscultation 
(Rush et al. 1998b; Courouce-Malblanc et al. 2007).  
 
1.4. Bronchoalveolar lavage (BAL) 
In healthy horses, the major cell populations in the BAL fluid (BALF) consist of 
alveolar macrophages (AM) (60%) and lymphocytes (35%). The other cell types – 
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neutrophils, eosinophils, mast cells and epithelial cells – are usually in negligible 
numbers (Robinson 2001). The most consistent cytologic abnormality in BALF from 
horses with heaves is neutrophilic inflammation with neutrophils forming 50-70% of the 
total cell count (Rush et al. 1998a; Robinson 2001). Comparison of cellular and 
molecular components of BALF harvested from different segments of the equine lung 
suggest that a single BALF sample is representative of the entire lung in these horses 
(McGorum et al. 1993b). 
BAL analysis is one of the most consistent tools used to diagnose horses with 
lower respiratory pathology. However, there are inconsistencies in the reports regarding 
the order of appearance of the changes in BAL findings compared to the appearance of 
changes in the clinical signs. This point will be discussed in detail in section 1.6.  
 
1.5. The type of immune reaction, cells and cytokines involved in the 
pathogenesis of heaves 
In 1971 the term ‘equine chronic obstructive pulmonary disorder (COPD)’ was 
introduced by Sasse to describe the syndrome of airway inflammation and obstruction 
that affects the mature horse (Sasse 1971). This name portrays the chronic nature of the 
disease and the obstruction of the airways associated with it. In addition, the mucus and 
neutrophilic accumulation in the airways greatly resemble human lung disease of the 
same name. With the growing understanding of the pathogenesis of heaves in horses, the 
term COPD is now thought to be misleading; human COPD is a progressive disease with 
little reversibility which usually results from smoking. However,  heaves is characterised 
by reversible airway narrowing due to bronchospasm that more closely resembles human 
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asthma (Robinson 2001). The type of immune reaction, including the cells and cytokines 
involved in equine heaves, should also be taken into account when choosing an accurate 
terminology for this disease.  
Neutrophilic pulmonary inflammation is the most consistent BALF abnormality in 
horses with heaves during disease exacerbation. There are contradictory results in 
macrophage numbers and total cells counts in horses with heaves which may be due to 
differences in disease duration, environmental antigen exposure, standardization of BAL 
technique, secondary bacterial infection and disease severity in the study population 
(Rush et al. 1998a).  
Clinical signs of heaves are exacerbated following exposure of the horses to dusty 
hay which suggests an allergic reaction to the moulds and fungi in the hay (Lavoie et al. 
2001). In addition, the positive passive cutaneous anaphylaxis test observed using sera 
from horses with heaves (Eyre 1972) as well as the elevated levels of IgE in BAL of 
affected horses (Schmallenbach et al. 1998; Horohov et al. 2005) points to  a type I 
hypersensitivity reaction. On the other hand, the neutrophilic inflammation in airways of 
horses with heaves could suggest an involvement of a type III hypersensitivity reaction 
(Lawson et al. 1979; Madelin et al. 1991). Inconsistencies were also found when 
attempting to define the predominant T-cell population, CD4 or CD8 T-cells, in blood 
and BAL of horses with heaves (McGorum et al. 1993b; Watson et al. 1997; Kleiber et 
al. 1999). The further divergence in CD4+ T helper cells (Th) into Th1 and Th2 subsets 
was extensively studied for better understanding of the pathogenesis of chronic airway 
inflammatory diseases. Cytokines such as IL-4, IL-5 and IL-13 that are produced by Th2 
cells are associated with allergic inflammation, while interferon-gamma (INF-γ) is 
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associated with cell-mediated immunity which characterizes the Th1 response. BAL cells 
retrieved from heaves affected horses were shown to have a mixed response and while 
some reports showed an increased expression of IL-4 and IL-5 mRNA, (Cordeau et al. 
2004) others showed an increased expression of INF- γ (Giguere et al. 2002). Taking 
together all of the above, it is suggestive that heaves is a combined response with both an 
allergic component as well as an inflammatory one. The variation between studies might 
be a result of methodological factors, disease definition and sampling time (Robinson 
2001; Horohov et al. 2005). 
Neutrophils are widely known as the host defence against bacterial pathogens as 
these cells release toxic proteases and oxygen-free radicals. However, neutrophils were 
also shown to play a major effector role in lung diseases that are of non-infectious origin, 
including acute asthma in humans (Ordonez et al. 2000) and acute respiratory distress 
syndrome (Nys et al. 2002). Occupational pulmonary diseases, such as cotton worker’s 
lung, are another group of human non-infectious pulmonary disorders that is mediated by 
neutrophils and to a great extent parallels equine heaves (Liebers et al. 2006). The 
morphology of neutrophils isolated from BALs of heaves-affected horses differs from the 
cytological findings in pulmonary bacterial infections in that the neutrophils appear 
normal, without evidence of toxicity or bacterial phagocytosis. In addition, the 
epidemiological pattern of heaves, characterized by individual older horses being 
affected, contrasts with the pattern in infectious respiratory disease, where large numbers 
of in-contact horses (especially younger animals) are affected. The widely accepted 
viewpoint that neutrophils equal infection and eosinophils equal allergy has recently been 
challenged. While the eosinophils are indeed the major inflammatory cells in the airways 
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of chronic stable asthmatics, the neutrophils have recently been implicated as the 
predominant cells in acute severe asthma in human patients (Ordonez et al. 2000; 
Robinson 2001).  
 
1.6. The role of neutrophils in equine heaves  
Although investigators have correlated the proportion of neutrophils in airway 
secretions with clinical disease severity (Vrins et al. 1991) and neutrophils are 
consistently recruited to the airspaces of susceptible animals after at least 5 h of challenge 
(Brazil et al. 2005), some studies have demonstrated accumulation of neutrophils without 
evidence of airway obstruction (Freeman et al. 1993; Tremblay et al. 1993) and in some 
animals airway dysfunction develops prior to or without significant pulmonary neutrophil 
sequestration (Naylor et al. 1992). These discrepancies may reflect the heterogeneity in 
the inflammatory and functional airway responses within a population of animals 
classified as heaves-susceptible as well as the low sensitivity of conventional pulmonary 
function tests. Nevertheless, it is still well believed that recruitment of neutrophils to 
lungs of heaves susceptible horses is a major component in the induction and 
maintenance of the disease (Brazil 2001). In heaves-susceptible horses neutrophil 
recruitment was shown to be induced by hay and straw challenge (Jackson et al. 2000) 
and by inhalation of endotoxin (Pirie et al. 2001) and aqueous mould extracts (Pirie et al. 
2002). These challenge agents stimulate production of an array of chemotactic mediators 
such as IL-8 and macrophage inflammatory protein-2 alpha (MIP-2α) by resident airway 
cells (e.g. alveolar macrophages and epithelial cells) (Franchini et al. 1998). Following 
short duration (5 h) challenge neutrophil numbers in BALF may rise 50-fold, reaching a 
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peak approximately 24 h after challenge began. Neutrophil numbers then fall, returning to 
baseline levels by 4 days (Brazil et al. 2005). Neutrophil kinetics during prolonged 
challenge are less well characterised. Persistence of increased nuclear factor-kappaB 
(NF-κB) activity in bronchial cells and accompanying lung dysfunction has been reported 
up to 21 days after removal of horses from the challenge environment (Bureau et al. 
2000a; Bureau et al. 2000b).  
There is substantial evidence for neutrophil activation in vivo and lung injury in 
heaves. One such evidence is the direct measurement of neutrophil secretory products 
(usually proteinases) in BALF; increased levels of matrix metalloproteinase-9 (MMP-9) 
were detected in BALF of heaves-susceptible horses after inhalation of different dust 
components (Raulo et al. 2001; Simonen-Jokinen et al. 2005). The magnitude of airway 
neutrophilia also closely correlated with marked increase in BALF levels of equine 
neutrophil elastase (ENE) 2A (Deaton et al. 2005). Myeloperoxidase (MPO) 
concentration, a marker of neutrophil accumulation and activation as well as the absolute 
and relative neutrophil counts, was shown to be greater in BALF of horses with an RAO 
crisis than in the control horses. In contrast, blood neutrophil counts and plasma MPO 
values were similar in both groups (Art et al. 2006). 
Additional evidence is the detection of neutrophil-mediated disruption of 
pulmonary homeostasis. Acute heaves is associated with a significant increase in markers 
of oxidative stress. The glutathione status in the pulmonary epithelium lining fluid was 
found to be significantly different in heaves-affected horses in acute crisis compared to 
healthy horses, indicating the occurrence of oxidative stress. When heaves-affected 
horses were in crisis their reduced glutathione and total glutathione remained unchanged 
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but their oxidised glutathione and glutathione redox ratios were significantly increased 
compared to remission, which supports the hypothesis that oxidative stress is associated 
with lower airway disorders occurring in heaves (Art et al. 1999). 
In addition to the cytotoxic granules released by activated neutrophils, these 
primed neutrophils are also able to generate and release soluble mediators, with 
significant inflammatory regulatory role. Hence, neutrophils may become the dominant 
source of pro-inflammatory cytokines which drive the ongoing airway inflammation (e.g. 
TNFα, IL-8, IL-1β, IL-6 and MIP-2) (Brazil 2001).  
Increased numbers of apoptotic neutrophils have been observed in BALF during 
the resolution phase of an acute episode of heaves and more particularly an increase in 
alveolar macrophages that have ingested intact apoptotic neutrophils was detected during 
this stage (Brazil et al. 2005). Nevertheless, during crisis, granulocytes retrieved from 
BALF of heaves susceptible horses demonstrated a significant delay in apoptosis 
compared with blood granulocytes from the same horses and blood and BALF 
granulocytes from healthy horses (Turlej et al. 2001). 
 
1.7. The contribution of endotoxin to the pathogenesis of Heaves 
Inhaled endotoxins are an important cause of human pulmonary disease, with the 
severity of pulmonary inflammation and clinical symptoms experienced by subjects 
exposed to organic dusts being related to the endotoxin concentration of the inhaled dust 
(Smid et al. 1994; Vogelzang et al. 1998). In addition, the severity of human asthma has 
been related to the level of endotoxin exposure (Michel et al. 1991; Rizzo et al. 1997), 
suggesting that inhaled endotoxin may potentiate the inflammatory response to allergens 
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in atopic subjects. Several studies were performed in an attempt to understand the 
contribution of endotoxins in the pathogenesis of heaves.  Pirie et al. suspected that the 
method of mould extract production is likely to result in endotoxin contamination, and 
therefore measured the response of heaves-susceptible horses to Aspergillus fumigatus 
extract inhalation before and after LPS depletion. Depletion of LPS from the mould 
extracts resulted in a significant reduction in airway neutrophil numbers and increase in 
arterial oxygen tension (Pirie et al. 2003b). The inflammatory response was shown to be 
re-established by adding endotoxin back to the endotoxin-depleted hay dust (Pirie et al. 
2003a).  An earlier investigation, conducted by the same group, on the pulmonary effects 
of inhaled endotoxin in control and heaves-susceptible horses showed a no-response 
threshold lower for the heaves group (<20 μg for airway inflammation; 200 to 2000 μg 
for lung dysfunction) than for the control group (20 to 200 μg for airway inflammation; 
>2000 μg for lung dysfunction). Comparison of the effects of acute LPS inhalation and 
hay/straw challenges suggested that inhaled endotoxin is not the sole cause of heaves. 
However, a 5 h exposure to poor air hygiene equates to an LPS dose of 160 μg. This dose 
exceeds the threshold dose of LPS which causes inflammation in horses with 
asymptomatic heaves (20 μg). Hence, endotoxin is likely to contribute to airway 
inflammation, both in heaves horses and in normal horses when they are exposed to high 
levels in poor stable environments (Pirie et al. 2001).  
 
1.8. Toll-like receptors  
As mentioned above, microbial-derived products, such as endotoxin, were shown 
to play an important role in the pathogenesis of heaves. Pathogen-associated molecules or 
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Pathogen-Associated Molecular Patterns (PAMP) enable innate immune cells to 
discriminate between ‘self’ and ‘non-self’ since they are specifically generated by the 
pathogen and not by the host. These PAMPs are recognized by pattern recognition 
receptors such as the Toll-like receptors (TLRs). The prototypic receptor Toll was first 
identified in the fruit fly Drosophila, but there are at least 13 identified mammalian 
TLRs, to date, that share similarities in their extracellular and intracellular domains 
(Brikos and O'Neill 2008). The TLRs act as primary sensors that detect a wide variety of 
microbial components and elicit innate immune responses. All TLR signalling pathways 
culminate in activation of the transcription factor NF-κB, which controls the expression 
of an array of inflammatory cytokine genes (Uematsu and Akira 2006; Kawai and Akira 
2007). TLR2 and TLR4 are the best characterized TLRs.  TLR4 is crucial for the 
recognition of endotoxin, in particular lipopolysaccharide (Schwartz 2001; Togbe et al. 
2007), and this is supported by the fact that TLR4-deficient mice were shown to be 
hyporesponsive to LPS (Hoshino et al. 1999). TLR4 is expressed in a variety of cell types 
within the lung, including pulmonary epithelial cells (Monick et al. 2003; Ainsworth et 
al. 2006), alveolar macrophages (Fernandez et al. 2004; Singh Suri et al. 2006), 
endothelial cells (Andonegui et al. 2003; Singh Suri et al. 2006) and airway smooth 
muscle cells (Morris et al. 2005), and its expression can be stimulated by LPS itself 
(Singh Suri et al. 2006). Stimulation of TLR4 leads to production of cytokines, such as 
interleukin-8 (IL-8) (Gon et al. 2004), TNFα, and IL-6 (Gon et al. 2004; Jeyaseelan et al. 
2005; Baumgarten et al. 2006).  TLR2 recognizes various microbial components, such as 
lipoproteins/lipopeptides and peptidoglycans from gram-positive and gram-negative 
bacteria, and lipoteichoic acid from gram-positive bacteria, a phenol-soluble modulin 
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from Staphylococcus aureus, and glycolipids from Treponema maltophilum (Takeuchi et 
al. 1999; Akira et al. 2006).  
The TLRs were shown to be crucial not only in mediating innate immunity, but 
specifically in the development of acute lung inflammation. Jeyaseelan et al. 
demonstrated that LPS-induced acute lung injury (ALI) in a mouse model is partially 
dependent on CD14 but fully dependent on TLR4, and that blocking TLR4 reduced the 
characteristic features of ALI, including an increase in the total WBC count, neutrophil 
influx and sequestration in the lung (Jeyaseelan et al. 2005). In addition, by use of TLR4-
deficient mice it was demonstrated that TLR4-dependent signalling cascades are critical 
for the induction of inflammatory cytokines (TNF, IL-1β, IL-6) and NO production after 
LPS exposure in the lung (Baumgarten et al. 2006). Recent investigations on the nature 
of TLRs in the horse’s lung revealed expression of TLR4 but not TLR2 in normal horse 
lungs; however an increase in lung expression of both TLR4 and TLR2 mRNA was 
observed 2 h after intravenous administration of LPS (Singh Suri et al. 2006). In addition, 
Berndt et al. demonstrated an involvement of TLR4 in the pathogenesis of heaves by 
showing an increase in TLR4 mRNA expression in bronchial epithelial cells from heaves 
horses exposed to stable dust and this increase in TLR4 mRNA correlated with IL-8 
mRNA expression as well as with neutrophilic airway inflammation (Berndt et al. 2007). 
Similar to heaves, environmental exposure to endotoxin has a crucial role in immune 
maturation and development of asthma, therefore TLR4 was suggested to be involved in 
this pathogenesis. Indeed, polymorphisms in the TLR4 gene were associated with a 
modified response to endotoxin in asthmatic patients (Werner et al. 2003; Adjers et al. 
2005).  
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1.9. Pulmonary Intravascular Macrophages (PIMs) 
In the lung, as in several other organs in the body, macrophages reside in various 
anatomical compartments. For example, in addition to well characterized alveolar 
macrophages, the lung also contains interstitial, airway and, in some species, 
intravascular macrophages. Mononuclear phagocytes constitute a dynamic population of 
cells in the lung. Large numbers of monocytes pass through the pulmonary circulation 
and may become transiently sequestered in pulmonary capillaries. Some of these 
sequestered cells migrate into the interstitium or alveolar spaces, and differentiate into 
mature macrophages. In some domestic animal species such as cattle, goats, sheep and 
pigs (Atwal and Saldanha 1985; Warner et al. 1986; Wheeldon and Hansen-Flaschen 
1986; Winkler 1988; Singh et al. 1995; Brain et al. 1999), monocytes permanently adhere 
to the endothelium and differentiate into mature pulmonary intravascular macrophages 
(PIMs). One of the earliest reports showing the presence of PIMs in calf lungs was 
published in 1974 (Rybicka et al. 1974), followed by the evidence of erythrophagocytosis 
by PIMs in goats (Atwal and Minhas 1992). The PIMs in the equine lungs were first 
described in 1992 by Atwal and colleagues (Atwal et al. 1992) and subsequently in 1994 
by Longworth and colleagues (Longworth et al. 1994). There are reports of occurrence of 
smaller populations of PIMs in rabbit and cat lungs as well (Brain et al. 1999). In pigs 
and sheep, the PIMs were shown to be sequestered within 4 weeks of their birth (Winkler 
and Cheville 1985, 1987). However, there are no data on the ontogeny of PIMs in horses. 
Currently, there are no molecular or evolutionary explanations for the intriguing 
recruitment of PIMs in some host animal species and their absence in others, such as dogs 
and rats.  
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It has been known for many years that PIM-containing animal species are more 
prone to lung inflammation (Frevert and Warner 1992). For example, an injection of 
0.003-1.3 µg of E. coli LPS/kg body weight induces pulmonary hypertension and cardio-
pulmonary shock in horses (Frevert and Warner 1992). In addition when Pseudomonas 
aeruginosa bacteria are intravenously injected into sheep or pigs, the pulmonary 
capillaries become congested with red cells, neutrophils, platelets, lymphocytes and fibrin 
clumps, and intravascular macrophages. These morphologic changes accompany 
physiological changes, such as pulmonary hypertension and hypoxemia. In contrast, rats 
injected intravenously with Pseudomonas aeruginosa show almost no pulmonary 
morphologic changes and no features of pulmonary failure. In the rat, most bacteria are 
retained in the liver by Kupffer cells, and it is the hepatic sinusoids that are congested 
with neutrophils and platelets (Crocker et al. 1981; Warner et al. 1987).  A series of 
experiments provided conclusive linkage between PIMs and pulmonary responses in 
sheep. Neonatal lambs have very few PIMs and show no hemodynamic response to 
Monastral blue or liposomes (Longworth et al. 1992). However, PIM sequestration in 
lambs by two weeks of age is accompanied by enhanced vascular response to the same 
treatment; this hypertensive response is eliminated by removing the PIMs (Sone et al. 
1997).  
Interestingly, depletion or inactivation of PIMs in adult horses also blocked 
endotoxin-induced increase in pulmonary arterial pressures and reduced expression of IL-
1β (Longworth et al. 1996; Parbhakar et al. 2005). Endotoxin-induced pulmonary 
vascular responses are generally attributed to production of vasoactive substances such as 
thromboxanes by the PIMs. This contention is supported by in vitro data showing that 
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porcine PIMs produce more arachidonic acid metabolites compared to the alveolar 
macrophages (Chitko-McKown et al. 1991; Chitko-McKown and Blecha 1992). Taken 
together, the evidence shows a causal relationship between PIMs and endotoxin-induced 
pulmonary vascular responses.  
The uptake of endotoxins and other bacterial products is done through molecules 
such as Toll-like receptors and CD14 (Aderem 2001).  Recently, the first data on the 
expression of TLR4 in PIMs in horse (Singh Suri et al. 2006), cattle and pigs (Wassef et 
al. 2004; Singh Suri et al. 2006) was reported. TLR4 expressed in PIMs seems to be a 
major component of total TLR4 expression in horse lungs since depletion of these cells 
significantly reduced lung expression of TLR4. Although TLR2 protein expression was 
not examined, TLR2 mRNA expression was not detected in lungs from normal horses. 
The strategic location of TLR4-enriched PIMs provides them with unique opportunities 
to sense and respond to blood-borne and perhaps also air-borne endotoxins. Indeed, 
TLR4 was shown to colocalize with E. coli LPS in cytoplasm and nucleus of equine 
PIMs (Singh Suri et al. 2006). The uptake of LPS by equine PIMs is in line with their 
previously reported significant phagocytic activity for tracer particles (Singh et al. 1994; 
Singh et al. 1995). 
PIMs location in lung microvessels creates a unique structural potential for 
exaggerated pulmonary response to endotoxins. It is known that interaction of endotoxin 
with TLR4 or the uptake of LPS by macrophages activates them (Fujihara et al. 2003). 
Macrophages, once activated, secrete mediators such as IL-1β and TNFα to induce 
expression of adhesion molecules on lung microvascular endothelium (Springer 1994; 
Antonelli et al. 2001). Furthermore, production of metabolites such as thomboxanes in 
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lung microvessels modifies pulmonary hemodynamics. As a result, neutrophils start to 
accumulate in the lungs and amplify lung inflammation through free oxygen radicals and 
cytokines. Based on the role of macrophages in endotoxin-induced responses in general, 
it is conceivable that TLR4 expressing PIMs will amplify lung inflammation in horses. 
This contention seems to be true based on data from PIM-depletion studies in sheep, 
cattle and horses (Sone et al. 1997; Sone et al. 1999; Singh et al. 2004; Parbhakar et al. 
2005).  
There is still a great gap in our knowledge of the biology of the PIMs due to our 
inability to isolate them. PIMs are intimately attached to the capillaries’ endothelium and 
hence cannot be removed even with drastic enzyme treatments (Rogers et al. 1994). Our 
growing understanding of the pathophysiological role of PIMs is through in vivo studies 
of selectively depleting or inactivating the PIMs and comparing the outcomes between 
non-depleted and depleted animals. Gadolinium chloride, a rare earth lanthanide, was 
shown to kill and eliminate macrophages as well as interfere with their phagocytic 
function (Mizgerd et al. 1996). In species having PIMs, the macrophages affected the 
most by intravenous GC injection are the PIMs due to the “first pass” of the chemical 
through the lung following administration in jugular vein (DeCamp et al. 1992; Staub 
1994; Singh and de la Concha-Bermejillo 1998). Consequently there may be little spill 
over of GC to Kupffer cells thus reducing the possibility of damage to these cells. 
Gadolinium chloride has been used to remove PIMs in several animal species such as 
sheep, calves and horses (Singh and de la Concha-Bermejillo 1998; Singh et al. 2004; 
Parbhakar et al. 2004).  
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The role of PIMs in the development of RAO in horses has not been addressed. 
One major difference between this pathology and those discussed above regarding the 
PIMs is that the dust and endotoxin in RAO are introduced via the airway and are not 
blood borne. There are some studies that demonstrate the involvement of PIMs in lung 
infections. For example, after intratracheal inoculation with Haemophilus 
pleuropneumoniae, the relative volume of intravascular macrophages in pig lungs 
increased in areas of inflammation and necrosis and it was concluded in this study that 
the intravascular macrophages clear cellular and acellular debris from the blood in 
pneumonitis (Bertram 1986). A similar role has been proposed for PIMs in the pulmonary 
response to intratracheal inoculation of Mannheimia haemolytica (Whiteley et al. 1991; 
Singh et al. 2004) in calves  and in experimentally induced African Swine Fever in pigs 
(Sierra et al. 1990; Carrasco et al. 1992; Carrasco et al. 2002).  
Much of the current research focuses on whether PIMs are induced in humans in 
certain pathological conditions. Human lungs do not contain PIMs under normal 
circumstances and foreign particles in the circulation are localized in the liver, 
phagocytised by Kupffer cells (Warner 1996; Longworth 1997). However, gram-negative 
septicaemia or endotoxemia in humans often leads to acute lung injury or Adult 
Respiratory Distress Syndrome (ARDS) and it is not understood how pulmonary 
inflammation develops from systemically introduced pathogens. Sheep and pigs are both 
used as experimental models for ARDS in humans (Eiznhamer et al. 2004; Wang et al. 
2008). Because PIMs are believed to be absent in humans, the use of sheep and pigs as a 
model to study human lung inflammation may not provide applicable data. There is, 
however, a possibility of recruitment of PIMs in the lungs of humans following 
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physiological stress which makes their pulmonary vasculature similar to that in species 
with resident intravascular macrophages (Longworth 1997). One ultrastructural report 
showed PIMs in biopsies taken from human patients undergoing thoracotomies for 
excision in noninfectious lung diseases (Dehring and Wismar 1989). In addition, there is 
some indirect evidence to support accumulation of mononuclear phagocytes in lung 
vasculature of patients with liver disease (Keyes et al. 1973; Imarisio 1975). As 
mentioned above, the pathogenesis of RAO in horses has some similarities mainly to 
human asthma, but also to COPD and human occupational lung diseases, and exposure to 
the triggering molecules in all these pathologies occurs though the airways. Hence, 
studying the role of PIMs in the development of heaves in horses may shed some light on 
the role of these cells in several human pulmonary pathologies.  
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2. HYPOTHESIS  
My working hypothesis is that the depletion of PIMs in horses will attenuate the 
activation of airway inflammatory cells and reduce proinflammatory cytokines 
production in the development of heaves and in consequence will attenuate clinical signs 
of heaves and lower the response of BAL cells to a secondary challenge with LPS.  
 
3. OBJECTIVES 
The study was undertaken to investigate: 
3.1. the effect of PIM depletion in horses on: 
3.1.1. the development of clinical signs of heaves 
3.1.2.  the total alveolar cells, alveolar macrophages and neutrophils in the alveolar 
space in the development of heaves 
3.1.3.  the activation state of BAL cells  
3.1.4. the activation state of BAL cells after a secondary in vitro challenge with LPS 
3.2.  the presence of septal macrophages in human lungs from healthy and COPD or 
asthmatic patients  
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4. MATERIALS AND METHODS 
4.1. Animals 
Nine light type mares (400-600 kg), 10 to 20 years of age, with a history of 
recurrent airway obstruction in the last two years were studied. The mares were kept in 
outdoor paddocks with sheds. They were maintained on alfalfa cubes  and challenged 
with mouldy hay and had free access to water and trace-mineralized salt, in accordance 
with the University of Saskatchewan’s Animal Care and Use Committee.  Mares had no 
signs of an ongoing systemic disease at initial physical examination. Episodes of heaves 
were induced by feeding the horses with mouldy hay (2 year old hay) in a round bale 
feeder for 7 days and remission was achieved by feeding the horses with alfalfa cubes for 
a period of 3 weeks (Figure 4.1).  
Physical examination including heart rate, respiratory rate, rectal temperature, 
auscultation with and without a rebreathing bag and evaluation of nasal flaring, nasal 
discharge, and abdominal effort was performed periodically, before and after treatments 
and prior to all BALs. A subjective clinical assessment of the respiratory effort was done 
using a Total Clinical Score (TCS) system adapted and modified from previous published 
studies (Naylor et al. 1992; Rush et al. 1998a; Berndt et al. 2007; Courouce-Malblanc et 
al. 2007). The intensities of the clinical signs were scored from normal to severe as 
indicated in Table 4.1.  Results represent one time point of clinical assessment done for 
each treatment just prior to the BAL procedure. The TCS was calculated for each mare by 
adding the values for each clinical sign; hence the TCS can range between 4 to 13. In 
addition the effect of the treatments on each clinical sign was evaluated by calculating the 
sum of scores from all mares for each clinical sign.  
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Table 4.1. Total clinical scores parameters and their description 
Parameter/Clinical sign Score Description 
Abdominal effort 
1 Normal (no signs of dysfunction) 
2 Moderate abdominal component 
3 Severe, marked abdominal component 
Nasal flaring 
1 Normal (no signs of flaring) 
2 Moderate nostril flaring 
3 Severe, continuous flaring during each respiration 
Coughing 
0 No coughing  
1 Coughing during the examination 
Auscultation 
1 Normal lung sounds 
2 Occasional wheezes and crackles 
3 Wheezes and crackles during each respiration 
Auscultation after a 
rebreathing bag 
1 Normal lung sounds 
2 Occasional wheezes and crackles 
3 Wheezes and crackles during each respiration 
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Figure 4.1. Photos of mares in the study demonstrating the different eating patterns when 
fed with: hay in round bales (a,b) and alfalfa cubes (c) 
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4.2. Study design 
Horses were randomly assigned to two treatment groups with five mares in one 
group and the remaining four in the second group. The study design was a modified 
cross-over, in which all horses ultimately received all treatments. The treatments 
included: 1. pasture/cubes no gadolinium chloride (GC) treatment (Cb) – remission or 
non-heaves induced horses;  2.  Mouldy hay no GC treatment (MH) – heaves induced 
horses; 3. Pasture/cubes and intravenous administration of GC (Cb-GC); 4. Mouldy hay 
and intravenous administration of GC (MH-GC). The order of the treatments was 
different in each group. Horses in group 1 (n=5) received treatment 1 to 4 in the order 
stated above, while horses in group 2 (n=4) received treatment in the order 3, 4, 1 and 2. 
Following induction of heaves, horses were fed with alfalfa cubes for 3 weeks to achieve 
remission. In addition, after performing BALs horses were fed with cubes for 2 weeks to 
allow reconstitution of the alveolar cells as well as recovery from the irritation that 
occurred during the BAL procedure. For the mouldy hay challenges, horses received 3 
treatments of GC, the first 2 days prior to the MH while the horses were still on cubes, 
with 2 more repeats at 96 h intervals. The third administration occurred one day prior to 
the BAL. The treatment plan is summarized in Figure 4.2. 
Whole blood was collected in EDTA tubes prior to each BAL for complete blood 
cells counts and differentials 
 
 
.  
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Figure 4.2. A schematic summary of the treatment plan. The box on the right indicates 
the order for group 2.  
 
4.3. Gadolinium chloride treatment 
Gadolinium Chloride, GdCl3 · 6H2O (Sigma-Aldrich, Oakville, ON, Canada), 
was administered at a dose of 10 mg/kg intravenously (jugular vein) in 500 ml of saline 
over 30 min. Heart rates were recorded before and after the infusion. It has been 
previously shown that this dose of GC causes significant depletion of PIMs and new 
PIMs are recruited after 72 h of the treatment (Parbhakar et al. 2004). The GC treatments 
are outlined in the preceding section.  
 
4.4. Bronchoalveolar lavage 
Horses were sedated with acepromazine (0.02 mg/kg intravenous) followed by 
detomidine (0.01 mg/kg intravenous) and butorphenol (0.01 mg/kg intravenous). A 3m 
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video-endoscope (Olympus SIF-100, Olympus Canada Inc., Markham, ON, Canada) was 
passed intranasally and directed to the right cranial lobar bronchus to instill 500 ml of 
warm solution of sodium chloride 0.9%, sodium bicarbonate 0.06%, pH 6.5, at 370C. 
Following instillation, the fluid was aspirated with a pump (Millipore GE 5KH33DN16X 
mechanical pump, Mississauga, ON, Canada) and collected and stored in sterile flasks on 
ice for further analysis. The pressure of the pump was adjusted to prevent airway 
collapse. The procedure was repeated for the left lung. On each side of the lung about    
20 ml of 2% Lidocaine HCl (Ayerst Veterinary Labs, Guelph, ON, Canada) was injected 
prior to lavage to relieve the irritation and minimize the coughing.  Total volumes of 
BALF were recorded. 
 
4.5. BALF processing 
After recording the total volumes, the BAL fluids were centrifuged at 2000rpm 
for 10min. Two hundred millilitres of the supernatant were collected from each BALF, 
aliquoted and stored at -800C. The cells were washed with RPMI-1640 medium 
(Invitrogen, Burlington, ON, Canada) containing 2 mM L-glutamine, 10mM Hepes, and 
5μg/ml gentamicin (Invitrogen, Burlington, ON, Canada) and were centrifuged again at 
400 g for 10 min. The supernatant was discarded and the cells were resuspended in 
RPMI-1640 medium containing 2 mM L-glutamine, 10 mM Hepes, 5 μg/ml gentamicin, 
and 10% horse serum (Invitrogen). 
 
  
25 
 
4.6. Analysis of cell populations in the BALF 
Total nucleated cell counts (TNCC) were determined by use of a hemocytometer. 
Total nucleated cell concentration (number of cells/ml) was calculated by dividing the 
TNCC by the corresponding volume of the BALF. The differential cell counts were 
determined by examination of 100 consecutive leukocytes on a cytospin preparation 
stained with Giemsa stain. Neutrophils and alveolar macrophages concentrations were 
calculated by multiplying the percentage of cells with the total nucleated cells 
concentrations. The evaluator performing the cell counts was blinded to the treatments.  
 
4.7. In vitro LPS challenge 
Cells were distributed to Eppendorf tubes at a volume of 1ml in each tube, and a 
concentration of 5X106 cells/ml. The cells were stimulated with Escherichia coli LPS    
(1 μg/ml, strain 0127:B8) (Sigma-Aldrich, Oakville, ON, Canada) or media (control) for 
different time points (0, 5, 10, 15, 30, 60 min and 6 h). Following each time point the 
cells were spun down. The supernatants were collected and stored at -800C and cells were 
frozen in liquid nitrogen and stored at -800C.  
 
4.8. Whole blood processing 
Forty millilitres of whole blood was collected in heparin vacutainer tubes. 
Sedimentation of red blood cells was done by mixing the whole blood with a 6.5% T75 
solution of Dextran (1:1 v/v) and allowing rouleaux formation over a one hour period. 
The leukocyte/platelet-rich plasma layer above was then aspirated and centrifuged at    
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400 g for 10 min. The remaining red blood cells were lysed by adding 9 ml of hypotonic 
solution (distilled water) to the cell pellet for 18sec following by 1 ml of 10X concentrate 
HBSS (Sigma-Aldrich, Oakville, ON, Canada) to stop the lysis. The cells were 
centrifuged again at 400 g for 10 min, counted using a hemocytometer and were 
resuspended with RPMI-1640 medium containing 2 mM L-glutamine, 10 mM Hepes,     
5 μg/ml gentamicin, and 10% horse serum (Invitrogen) to a final concentration of             
5X106 cells/ml. The cells were distributed to two Eppendorf tubes (1 ml/each), spun 
down and after discarding the supernatant the pellets were frozen in liquid nitrogen and 
stored at -800C.  
 
4.9. Enzyme linked- immunosorbent assay (ELISA) for tumor necrosis factor-α 
(TNFα) 
TNFα protein concentrations were determined using the equine TNFα ELISA 
screening set (Pierce, Endogen, Rockford IL, USA) both in the BAL supernatants that 
were obtained immediately following BAL collection (after the first centrifugation, 
representing the 0 h time point), and in cell supernatants that were collected from the 
BAL cells after 6 h of incubation with or without LPS.  The sandwich ELISA method 
was performed according to the manufacturer’s instructions. Samples from the 9 mares 
were loaded in duplicate wells (100 μl in each well). Negative controls (media, media + 
LPS (1 μg/ml) and reagent diluent) were also loaded in duplicate wells. Following 
addition of the stop solution, absorbance was measured using BMG-Labtech's-
NOVOstar-Microplate-Fluorometer (Biocompare, South San Francisco, CA, USA) at a 
450 nm wavelength.   
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4.10. RNA isolation and cDNA synthesis 
Total RNA was extracted from BAL cells and whole blood cells using an RNeasy 
Mini kit (Qiagen, Mississauga, ON, Canada) according to the manufacturer’s 
instructions. The integrity of RNA as well as its quantification was evaluated using a 
Thermo Scientific NanoDrop spectrophotometer (Thermo Fisher Scientific, ON, 
Canada). Following DNase treatment, the mRNA was reverse transcribed at 42ºC for          
30 min by using QuantiTect Reverse Transcription kit (Qiagen, Mississauga, ON, 
Canada) as per manufacturer’s instructions.  
 
4.11. Quantitative real time reverse-transcriptase polymerase chain reaction 
(qRT-PCR) 
The cDNA from the BAL cells was used for qRT-PCR analysis for the expression 
of tumor necrosis factor alpha (TNF alpha; GenBank Accession No. EU438779), 
interleukin 8 (IL-8; GenBank Accession No. AF062377), and toll-like receptor 4 (TLR4; 
GenBank Accession No. AY005808) genes using QuantiFast SYBR Green PCR kit 
(Qiagen, Mississauga, ON, Canada), as per manufacturer’s instructions. The 
glyceraldehyde-3-phosphate dehydrogenase gene (GAPDH; GenBank Accession No. 
AF157626) was used as the reference housekeeping gene. The reactions were performed 
using the primer pairs; 5’-TGTAGCAAACCCCCAAGCCGA-3’ and 3’-GCGGCTGA 
TGGTGTGGGTGAG-5’ for TNFα; 5’-ATGACTTCCAAGCTGGCTGTT-3’ and 3’-
ATGATTTCTGAGTTTTCGCAG-5’ for IL-8; 5’-GCCTTCACTACAGAGAC 
TTCATTC-3’ and 3’-GGGACACCACGACAATAACTTTC-5’ for TLR4; and 5’-
TCACCATCTTCCAGGAG-3’ and 3’-GTCTTCTGGGTGGCAG-5’ for GAPDH. Real-
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time PCR analysis was performed using the MX3005P LightCycler (Stratagene, La Jolla, 
CA, USA). The cDNA was denatured at 95°C for 5 minutes. This was followed by 
amplification of the target DNA through 45 cycles of denaturation at 95°C for 30 
seconds, annealing at 55°C for 30 seconds and elongation at 60°C for 45 seconds. 
Relative expression levels (fold differences) were calculated after correction for 
expression of GAPDH, and relative to the results in the Cb treatment, using MxPro 
software (Stratagene). 
 
4.12. Collection of total airborne dust 
Total dust samples were collected from each setting environment (cubes and 
mouldy hay) as previously described (Kirychuk et al. 1998; Charavaryamath et al. 2005). 
Briefly, an air sampling pump (SKC Aircheck Model 224-PCXR4, SKC Inc., Eighty 
Four, PA, USA) was connected to sampling cassettes (SKC Inc.) placed in cassette 
holders (SKC Inc.). A 37 mm Polyvinyl Chloride (PVC) filter, 5.0 µm pore size (SKC 
Inc.) was placed in each cassette. While collecting the dust, the pump was placed in a bag 
which was carried by an operator and the cassettes were held 20-40 cm from the nostrils 
of a randomly chosen horse to collect airborne dust present in a horse’s breathing zone. 
This provides a more accurate indication of the amount of dust entering the respiratory 
tract than remote sampling. The pump flow rate (2.1 liter/min) was calibrated before and 
at the end of each sampling period using an air flow calibrator (Bios Dry-Cal DC-Lite 
Calibrator, Bios International Corporation, Butler, NJ, USA). The sampling period for 
both environments was 1h, and the same horse was used for both environments. 
Gravimetric analysis for total dust (milligram of dust/m3 of air [mg/m3]) was performed 
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by weighing the filters 3 times before and after dust collection and averaging the results. 
The method for calculating the total dust concentration was performed according to the 
NIOSH Manual of Analytical Methods (NMAM), fourth edition (Clere and Heart 1994). 
The filters were then placed in 50 ml polypropylene centrifuge tubes and stored at 4°C 
until endotoxin analysis was performed.  
 
4.13. Endotoxin evaluation 
Ten millilitres of sterile, nonpyrogenic water (LAL Reagent Water; BioWhittaker, 
Walkersville, MD) were added to each tube containing the filters and the Chromogenic-
end point Limulus Amoebocyte Lysate assay (Escherichia coli O55:B5; QCL-1000 
Chromogenic endpoint assay kits; Cambrex BioScience, Walkersville, MD, USA) was 
used to determine the airborne endotoxin and dust endotoxin concentration (endotoxin 
units/m3 of air [EU/m3] and endotoxin units/mg of dust [EU/mg]). The total concentration 
of endotoxin in the sampled air was calculated in a similar manner as the total dust 
concentration (Clere and Heart 1994). The assay has a sensitivity range of 0.1 EU/ml to 
1.0 EU/ml. Endotoxin samples are referenced to the RSE:EC-6 for conversion to ng/m3 
(10 EU = 1ng). The concentration of endotoxin in a sample is calculated from the values 
of solutions containing known amounts of endotoxin standard. 
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4.14. Light microscopy of human lung sections 
4.14.1. Histopathology 
The lung sections as well as the patients’ diagnoses were obtained from Dr. Rani 
Kanthan from the Department of Pathology, College of Medicine, University of 
Saskatchewan. These lung tissues were collected from patients who died due to non-
infectious pulmonary pathologies (COPD or Asthma) (n=8) and from those who died 
with no apparent lung pathology (n=6). Five μm thick sections were prepared from the 
paraffin-embedded human lung tissues and placed on glass slides. These were stained 
with hematoxylin-eosin. 
 
4.14.2. Immunohistology for human macrophages  
After removal of wax with xylene and rehydration in an ethanol series, the 
sections were incubated in 0.5% hydrogen peroxide in methanol for 20 min to quench 
endogenous peroxidase followed by pepsin treatment (2 mg/ml 0.01 N HCl) for 45 min 
for antigen retrieval. After blocking nonspecific sites with 1% bovine serum albumin for 
30min, mouse anti-human monocyte/macrophage antibody; MAC 387 (Serotec LTd, 
Kidlington, UK) at a 1:150 dilution was added to the sections for 60min followed by 
Polyclonal Goat anti-mouse peroxidase-conjugated secondary antibody (DAKO, 
Mississauga, ON, Canada) at a 1:150 dilution for 30 min. The antibodies were diluted in 
1% bovine serum albumin. The antibody reaction was visualized by use of a color 
development kit (Vector Laboratories, Burlington, ON, Canada). The slides were 
counterstained with methyl green (Vector Laboratories, Burlington, ON, Canada). The 
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negative controls for the immunohistology protocols included staining the lung sections 
with only secondary antibody and only primary antibody, and the positive control 
included staining the sections with rabbit anti-human von-Willebrand Factor (vWF) 
antibody at a 1:300 dilution (DAKO, Mississauga, ON, Canada). Positive septal cells 
were counted in 40X magnification in 5 randomly chosen fields. The evaluator was 
blinded to the clinical diagnoses of the samples. 
 
4.15. Statistical analysis 
All results were analyzed using computerized statistical software (Statistix 8 
Student Edition, Analytical Software, Tallahassee FL 32317, USA). The effect of drug, 
feed, and drug by feed interaction was analyzed with general Analysis of Variance test 
with a mare block. Differences between groups were analyzed with an All-Pairwise 
Comparison Test. Results of the human data were analyzed with a non-paired t-test. 
Different letters above graphs represent significant differences between the treatments. 
Differences were considered significant at P < 0.05.  
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5. RESULTS  
 
5.1. Airborne dust and endotoxin concentrations 
The mouldy hay (MH) environment contained a higher concentration of dust (3 
fold), endotoxin (20 fold), and endotoxin per milligram of dust (7 fold) than the cubes 
environment (Table 5.1).  
 
5.2. The effect of PIM depletion on the development of clinical signs of heaves 
Complete blood cells counts evaluated prior to each BAL were not different 
among the different treatments. Clinical evaluation performed prior to each BAL revealed 
a significant higher median of the total clinical scores when mares were fed with MH 
(MH) compared to Cubes (Cb) (Figure 5.1). When mares were fed with MH and received 
the GC treatment (MH-GC) the median of the total clinical scores was significantly lower 
than those without the GC treatment (MH). Gadolinium chloride treatment had no effect 
on the clinical scores when mares were fed with cubes.  
The effects of the different treatments on the five clinical signs chosen to 
comprise the clinical scores as well as the contribution of each clinical sign to the total 
clinical scorings are summarized in Table 5.2. While coughing, abdominal effort, 
auscultation and auscultation after a rebreathing bag were affected by the treatments, 
nasal flaring was not affected and hence, does not have an effect on the total clinical 
scores.   
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5.3. The effect of PIM depletion on the total alveolar cells, alveolar macrophages 
and neutrophils in the alveolar space in the development of heaves 
The total cells concentration in the BALF was significantly higher when mares 
were fed with mouldy hay (MH) compared to cubes (Cb) (Figure 5.2). When mares were 
fed with MH and received the GC treatment (MH-GC) the total cell concentration was 
not statistically different than that in the 3 other treatments. In addition, GC treatment had 
no effect on the total cell concentration when mares were fed with cubes.  
Mares fed with MH had significantly higher concentrations of neutrophils in the 
BALF compared to when they were fed with cubes (Cb) (Figure 5.3a, 5.3b). When mares 
were fed with MH and received the GC treatment (MH-GC) the neutrophil concentration 
was lower than without the GC treatment (MH), and this, as opposed to the total cell 
concentrations, was statistically significant.  Gadolinium chloride treatment had no effect 
on the neutrophil concentration when mares were fed with cubes.  
The different treatments and environments had no effect on the alveolar 
macrophage concentrations (Figure 5.4). 
 
5.4. The effect of PIM depletion on the activation state of BAL cells  
 
5.4.1. Tumor necrosis factor-alpha (TNFα) protein level and mRNA expression 
TNFα protein concentration was assessed using the ELISA method on both BAL 
supernatants that were obtained immediately following BAL collection (after the first 
centrifugation, representing the 0 h time point of the different treatments), as well as on 
cell supernatants that were collected from BAL cells obtained from the different 
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treatments and incubated with media for 6 h. The assay did not detect TNFα protein in 
the supernatants collected at the 0 h time point. After 6 h of incubation with media both 
protein concentration and mRNA expression were not different among the different 
treatments (Figures 5.5 and 5.6, respectively). 
 
5.4.2. Interleukin-8 (IL-8) mRNA expression 
IL-8 mRNA was quantified in BAL cells collected from the different treatment 
groups after 6 h incubation with media. When mares were fed with mouldy hay (MH) 
they showed significantly higher expression of IL-8 mRNA than when fed with cubes 
(Cb) (Figure 5.7). Gadolinium chloride treatment of mares fed with MH (MH-GC) 
resulted in significantly lower expression of IL-8 mRNA than without the gadolinium 
chloride treatment (MH). Gadolinium chloride treatment had no effect on the IL-8 
mRNA expression when mares were fed with cubes. 
 
5.4.3. Toll like receptor-4 (TLR4) mRNA expression 
TLR4 mRNA was quantified in BAL cells collected from the different treatment 
groups after 6 h incubation with media. When mares were fed with mouldy hay (MH) 
they showed significantly higher expression of TLR4 mRNA than when fed with cubes 
(Cb) (Figure 5.8). Mares fed with MH and administered GC (MH-GC) showed 
significantly lower expression of TLR4 mRNA than without the gadolinium chloride 
treatment (MH). Gadolinium chloride treatment had no effect on the TLR4 mRNA 
expression when mares were fed with cubes. 
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5.5. The effect of PIM depletion on the activation state of BAL cells after a 
second in-vitro challenge with LPS 
The ability of BAL cells recovered from different treatment groups to respond to a 
secondary challenge with LPS was compared. The cells were exposed to LPS in vitro for 
6 h. The TNFα, IL-8 and TLR4 mRNA expression levels of the media exposure (no LPS) 
is equivalent to the above results (section 5.4) with an addition of the protein and mRNA 
expression levels after LPS exposure. Statistical comparisons were preformed between all 
8 treatments.     
 
5.5.1. TNFα protein and mRNA expression 
The different treatments did not have similar effects on the TNFα protein 
concentrations as compared to the mRNA expressions. Following exposure to LPS, 
TNFα protein concentration was significantly lower in cells isolated from mares fed with 
cubes that received the GC treatment (Cb-GC) compared to the other three treatments, 
while the mRNA expression was significantly higher in mares fed with cubes (Cb, Cb-
GC) compared to MH (MH, MH-GC). Nevertheless, both TNFα protein concentration 
and mRNA expression were significantly higher following 6 h in vitro exposure to LPS 
compared to media (Figure 5.9 and Figure 5.10 respectively). 
 
5.5.2. Interleukin-8 mRNA expression 
Following exposure to secondary hit with LPS, the IL-8 mRNA expression was 
significantly higher in BAL cells isolated from MH as compared to those isolated from 
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Cb (Figure 5.11). Moreover, the expression of IL-8 mRNA following LPS exposure was 
significantly lower in BAL cells isolated from MH-GC, as compared to those isolated 
from MH. These differences were more pronounced following a second hit with LPS than 
without the second hit. 
 
5.5.3. TLR4 mRNA expression 
TLR4 mRNA expression was not significantly affected by the second hit with 
LPS (Figure 5.12). In both LPS and non LPS treated cells TLR4 mRNA expression was 
significantly higher in cells isolated from mares exposed to mouldy hay (MH) as 
compared to cubes (Cb) and was significantly lower in cells isolated from mares exposed 
to mouldy hay that received the gadolinium chloride treatment (MH-GC) as compared to 
without the treatment (MH).  
 
5.6. The presence of septal macrophages in human lungs from healthy and 
COPD/asthmatic patients 
Immunhistology staining of human lung sections revealed no significant 
differences in the number of MAC387-positive septal cells per field (X40) between 
healthy and COPD/Ashtmatic patients (Figure 5.13 a,b). However, there was a tendency 
(P = 0.10) for higher number of septal macrophages in the control subjects compared to 
the COPD/asthmatic subjects.  
Subjective evaluation of the same sections stained with hematoxylin and eosin 
revealed loss of normal pulmonary septal structures and fibrotic changes in some lungs of 
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COPD/asthmatic patients. In addition some of the sections from the control patients had 
marked inflammation, edema and pulmonary haemorrhage. 
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Table 5.1. Airborne dust and endotoxin concentrations and endotoxin content in dust 
 
 Airborne dust 
concentration (mg/m3)
Airborne endotoxin 
concentration (ng/m3) 
Endotoxin content in 
dust (ng/mg) 
Cubes 0.31 0.87 2.8 
Mouldy hay 0.94 18.25 19.4 
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Figure 5.1. Subjective total clinical scores of mares receiving the different treatments. 
The total scoring was determined by calculating the sum of the abdominal effort, nasal 
flaring, coughing, auscultation and auscultation after a rebreathing bag. The values 
represent total clinical score of an individual mare in each treatment; each mare is 
distinguished by a different shape. Horizontal bars represent the median clinical score of 
each treatment group. Different letters above represent significant differences between 
treatments (P < 0.05) 
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Table 5.2. The effects of the different treatments on the scoring of abdominal effort, 
nasal flaring, coughing, auscultation and auscultation after a rebreathing bag. The effects 
of Cubes (Cb); Cubes + Gadolinium chloride (Cb-GC); Mouldy hay (MH), Mouldy hay + 
Gadolinium chloride (MH-GC), on the respiratory effort determined by scores of the 
following clinical signs (from normal to severe signs): abdominal effort (Abd. Eff. 1-3), 
nasal flaring (Nas. Flar. 1-3), coughing (0, 1), auscultation (Ausc 1-3) and auscultation 
after a rebreathing bag (Rebreath 1-3). 
 
Actual sum of mares 
Clinical sign 
Possible range 
(sum of mares) Cb Cb-GC MH MH-GC 
Abd. Eff. (1-3) 9---27 11 10 21 14 
Nas. Flar. (1-3) 9---27 10 9 10 9 
Coughing (0,1) 0---9 0 0 4 2 
Ausc. (1-3) 9---27 10 10 20 15 
Rebreath. (1-3) 9---27 10 9 20 15 
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Figure 5.2: Total cell concentration (mean) in the BALF collected from mares in the 
different treatments. Error bars represent S.E.M. Different letters above bars represent 
significant differences between treatments (P < 0.05) 
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Figure 5.3a A cytospin of BAL from one representative mare which received the 4 
treatments: Cubes (Cb); Cubes + Gadolinium chloride (Cb-GC); Mouldy hay (MH), 
Mouldy hay + Gadolinium chloride (MH-GC). Alveolar macrophages – AM, Neutrophils 
– Neu, Eosinophils – Eo, Small mononuclear cells – SMC. X40 
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Figure 5.3b Neutrophil concentration (mean) in the BALF collected from mares in the 
different treatments. Error bars represent S.E.M. Different letters above bars represent 
significant differences between treatments (P < 0.05) 
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Figure 5.4. Alveolar macrophage concentration (mean) in the BALF collected from the 
different treatment groups. Error bars represent S.E.M. Different letters above bars 
represent significant differences between treatments (P < 0.05) 
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Figure 5.5. ELISA results (mean) for the TNFα concentration in BAL cells recovered 
from the different treatments. Error bars represent S.E.M. Different letters above bars 
represent significant differences between treatments (P < 0.05) 
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Figure 5.6. Real time PCR results (mean) of the fold difference in TNFα mRNA 
expression from BAL cells recovered from mares in the different treatments. Error bars 
represent S.E.M. Different letters above bars represent significant differences between 
treatments (P < 0.05) 
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Figure 5.7. Real time PCR results (mean) of the fold difference in IL-8 mRNA 
expression from BAL cells recovered from mares in the different treatments. Error bars 
represent S.E.M. Different letters above bars represent significant differences between 
treatments (P < 0.05) 
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Figure 5.8. Real time PCR results (mean) of the fold difference in TLR4 mRNA 
expression from BAL cells recovered from mare in the different treatments. Error bars 
represent S.E.M. Different letters above bars represent significant differences between 
treatments (P < 0.05) 
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Figure 5.9. ELISA results (mean) of the TNFα concentration from BAL cells recovered 
from mares in the different treatments after 6 h exposure to LPS or media. Error bars 
represent S.E.M. Different letters above bars represent significant differences between 
treatments (P < 0.05) 
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Figure 5.10. Real time PCR results (mean) of the fold difference in TNFα mRNA 
expression from BAL cells recovered from mares in the different treatments after 6 h 
exposure to LPS or media. Error bars represent S.E.M. Different letters above bars 
represent significant differences between treatments (P < 0.05) 
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Figure 5.11. Real time PCR results (mean) of the fold difference in IL-8 mRNA 
expression from BAL cells recovered from mares in the different treatments after 6 h 
exposure to LPS or media. Error bars represent S.E.M. Different letters above bars 
represent significant differences between treatments (P < 0.05) 
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Figure 5.12. Real time PCR results (mean) of the fold difference in TLR4 mRNA 
expression from BAL cells recovered from mares in the different treatments after 6 h 
exposure to LPS or media. Error bars represent S.E.M. Different letters above bars 
represent significant differences between treatments (P < 0.05) 
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Figure 5.13a Representative histology stained with hematoxylin-eosin (H&E) (A,C) and 
immunohistochemistry for MAC387 (B,D) in  human lung sections from control (A,B) 
and COPD/asthmatic subjects (C,D). Arrows and inserts represent septal macrophages. 
Original magnification: X10; inserts: X40 
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Figure 5.13b Numerical quantification (mean of counts in 5 fields of X40) of septal cells 
positive for MAC387 in human lung sections from control (n=6) and COPD/Asthmatic 
patients (n=8). Error bars represent S.E.M.  
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6. DISCUSSION 
The role of PIMs in the development of acute lung injury following endotoxemia 
has previously been addressed in different animal species. Horses were shown to contain 
resident PIMs and PIM depletion attenuated acute lung injury after intravenous 
administration of endotoxin. However, the role of these unique macrophages in the 
development of lung pathologies such as heaves, in which the pathogenic agent is 
introduced via the airways, remains to be investigated. I compared the development of 
heaves in normal and PIM-depleted horses to investigate the inflammatory role of these 
cells in the pathophysiology of equine heaves.  
 
6.1. Validation of the study design 
In order to investigate the involvement of PIMs in the pathogenesis of heaves, the 
first task was to be able to induce heaves in susceptible horses and to be able to achieve 
clinical remission. It is well documented that heaves is triggered by a dusty environment 
and it has been suggested that endotoxin in the dust is a major contributor to the 
development of this pathology (Pirie et al. 2001; Davis and Rush 2002; Pirie et al. 2003a; 
Pirie et al. 2003b). I introduced a “dusty” environment by feeding the horses with two 
year-old mouldy hay in round bales. The “clean” environment (low-dust) was achieved 
by feeding the horses with alfalfa cubes. The analysis of the dust and endotoxin 
collection revealed a higher concentration of airborne dust and endotoxin and higher 
concentration of endotoxin in dust in the MH environment than in the cubes environment. 
These findings are in accordance with a previous report (McGorum et al. 1998) which 
measured the amount of dust and endotoxin in conventional stables and in pasture; the 
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MH environment in the current experiment contained slightly lower levels of airborne 
dust and airborne endotoxin than was measured in conventional stables in the above cited 
report (0.94 vs. 2.74 mg/m3, 18.2 vs. 19.76 ng/m3, respectively), but more endotoxin 
content in the dust (19.4 vs. 7.57 ng/mg). The alfalfa cubes environment in our study 
contained less endotoxin content in dust than was reported for the pasture environment 
(2.8 vs. 4.85 ng/mg) which is considered, to date, the ideal environment to achieve 
remission from heaves. These findings are not surprising. The mares in this study were 
fed in outdoor paddocks, therefore the total dust and endotoxin in the air is likely to be 
lower than what is found in indoor stables. However, the hay was of poor quality and 
probably older and mouldier than hay in most conventional stables, which may have 
resulted in higher amount of endotoxin per milligram of dust in the current experiment. 
Hay given in round bales encourages the horses to bury their whole head in the hay, 
therefore, not only did the MH contain more dust and endotoxin than the cubes, but this 
eating pattern exposes the horses to higher levels of dust and endotoxin (Figure 4.1).  
Evaluation of the dust and endotoxin concentrations was performed in order to determine 
whether the environments introduced by us were able to mimic those previously reported 
to induce heaves and remission from heaves. Since this was not the main objective of this 
study, the collection procedure was performed only once, and compared to past 
publications.  Other than the endotoxin, several components of the hay dust such as 
moulds (Simonen-Jokinen et al. 2005) were also shown to contribute to the development 
of heaves. Assessment of the levels of these components in our environmental settings 
would have increased the validity of our study design. However, since endotoxin 
concentrations in stable dust were previously shown to exceed those causing symptoms in 
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man (McGorum et al. 1998) and endotoxin inhalation has been reported to elevate BALF 
neutrophil counts and MMP-9 levels in both heaves susceptible and healthy horses (Pirie 
et al. 2001; Nevalainen et al. 2002), I decided to focus on the endotoxin and dust 
concentrations.  
In this study design, mares were exposed to MH for 7 days to induce heaves, and 
thereafter were fed alfalfa cubes for 21 days to achieve remission. There are variations in 
the reports regarding the length of time horses should be exposed to a dusty environment 
to induce clinical signs of heaves (Leguillette 2003) and the length of time in which they 
should be in pasture to achieve clinical remission (Davis and Rush 2002; Couetil and 
Ward 2003; Leguillette 2003). This discrepancy is probably due to the chronic or 
recurrent nature of the disease. Horses that had previous exposure to a dusty environment 
and experienced heaves during their lifetime would be more susceptible and hence 
rapidly develop clinical signs. Furthermore, in addition to the type of food (Robinson et 
al. 2006), other environmental factors have been suggested to effect the development of 
heaves; such as bedding  (straw vs. wood shavings) (Couetil and Ward 2003), ventilation 
quality (Couetil and Ward 2003), outdoor/indoor facilities (Tremblay et al. 1993; Dixon 
et al. 1995) and weather (dry/humid, winter/summer) (Bowles et al. 2002). There is also 
great variability between individual horses with differences in susceptibility between 
horses (Laan et al. 2006). In an attempt to overcome this, my experiment was designed as 
a crossover study in which all horses ultimately received all treatments and the data was 
analyzed statistically by blocking the effect of the mare. Although a crossover design has 
the disadvantages of doubling the duration of the study as well as the carryover effects, it 
minimizes the potential for confounding factors, such as discussed above, since each 
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participant serves as his own control and substantially increases the statistical power of 
the trial so that it needs less participants (Hulley et al. 2001). The mares in my study had 
past exposure to dusty environment and a history of heaves. Therefore, they were 
considered susceptible to heaves. Feeding these susceptible mares with MH for a period 
of 7 days was sufficient to induce clinical signs of heaves, as indicated by the clinical 
scoring analysis. Several studies reported an improvement of the respiratory function of 
heaves horses 1 week after being turned outside on pasture (Leguillette 2003), while 
others showed remission of signs only after four to six weeks of putting horses in 
controlled environment or pasture (McGorum et al. 1993a; Vandenput et al. 1998; Davis 
and Rush 2002). In order to prove remission from heaves, assessment of the clinical signs 
is not sufficient and further tests should be performed such as BAL and intrapulmonary 
pressure (ΔPpl) analyses. While we did not confirm remission of heaves with BAL or 
other relevant tests, mares in this study were fed with alfalfa cubes for a period of 3 
weeks to achieve remission. It is possible that the mares did not achieve complete 
remission which would affect the results of the “non-heaves induced mares” by bringing 
them closer to the results observed in the “heaves-induced mares”; this further 
strengthens the significant differences that were found in this study.  
 
6.2. Depletion of PIMs attenuates the development of heaves 
Different agents such as clodronate (Sone et al. 1997), and tyloxapol (Staub et al. 
2001) have been used in research to inactivate or deplete the PIMs. Gadolinium chloride 
was shown to kill and eliminate macrophages as well as interfere with their phagocytic 
function (Mizgerd et al. 1996). It is believed that GC leaks into the cytoplasm following 
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its endocytosis and kills macrophages either by direct cell injury or apoptosis (Singh and 
de la Concha-Bermejillo 1998). Because phagocytosis of GC is a prerequisite for its 
efficacy, macrophages become its prime targets (Singh et al. 2004). The macrophages 
affected most by intravenous GC injection in vivo are those that reside within the 
vasculature (Kupffer cells, splenic macrophages and PIMs). In species having PIMs, most 
of the biological or other particulate material injected via jugular vein is removed by the 
PIMs due to the “first pass” in the lung. Consequently there may be little spill over of GC 
to Kupffer cells thus reducing the possibility of damage to these cells (DeCamp et al. 
1992; Staub 1994; Singh and de la Concha-Bermejillo 1998). However, the effect of 
intravenous administration of GC on the alveolar and interstitial macrophages is not well 
established because there are no data on the transport of GC across the blood-air barrier. 
If GC indeed leaks from the vasculature into the alveolar space and the interstitium, the 
outcomes seen in the current study could be partially due to the elimination of the 
alveolar or interstitial macrophages. It was previously shown that a single intravenous 
administration of GC did not affect alveolar or interstitial macrophages in rats 
(Bannenberg et al. 1995). However, multiple GC treatments (36 weekly injections) in 
lambs resulted in ultrastructural observations of GC-like material in endosomes of 
alveolar macrophages along with some signs of damage suggestive of apoptosis (Singh 
and de la Concha-Bermejillo 1998). Although the mares in my study received a total of 
four treatments with GC (one while exposed to cubes and three while exposed to MH), 
the alveolar macrophage concentrations were not affected by the treatments nor was there 
an increase in number of apoptotic cells observed on cytospin slides from BALF of mares 
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treated with GC. These findings suggest lack of effect of GC on alveolar macrophages in 
this study.  
The effect of GC on other cells in the lungs possessing phagocytic capabilities, 
such as neutrophils, dendritic cells, and endothelial cells was not assessed in this study. 
The consequences of inhibiting or depleting such cells would be similar to those seen in 
our study (i.e. attenuation of the inflammatory processes), due to a decrease in the 
chemotactic gradient and decrease in adhesion complexes expressed on the endothelium.  
The protocol used to deplete the PIMs in this study was similar to a previously reported 
protocol which showed the effect of intravenous administration of GC on the depletion of 
PIMs in horses (Parbhakar et al. 2004). In the above cited study, a continuous decline of 
PIMs was observed at 72 h after GC administration. In order to avoid a possibility of 
insufficient clearance of the GC by the PIMs and consequently its leakage and effect on 
Kupffer cells in the liver, I administered GC every 96 h. Since we did not rule out the 
effect of GC on other cells in the lung that could attribute to the inflammatory process, 
we must take caution in ascribing the outcomes of this study solely to the depletion of the 
PIMs. However, due to the avid phagocytic ability of macrophages, the effect of GC on 
other cells might be of less significance. 
The main objectives in this study were to determine whether depletion of the 
PIMs would attenuate the development of heaves in horses. The investigator performing 
the clinical examinations was not blinded to the treatments, which might raise the 
concern of biased results; nevertheless, the rest of the experiments (cells counts, protein 
and mRNA levels) were carried out by an investigator blinded to the treatments. 
Therefore, although the issue of bias may have played a role on the clinical assessment of 
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horses, it may not be of significance as the cellular and molecular results were parallel to 
the clinical scores.  
While exposure to MH resulted in higher clinical scores, GC-induced PIM 
depletion decreased the median clinical scores in heaves horses. The clinical signs chosen 
to compose the clinical scoring in this experiment were abdominal effort, nasal flaring, 
coughing, auscultation and auscultation after a rebreathing bag. These were not affected 
equally by the treatments. Robinson and colleagues reported that coughing cannot be 
assessed accurately by counting during brief periods due to its sporadic nature (Robinson 
et al. 2003). However, I found this clinical sign to be well affected by the different 
treatments and hence was an important addition to the total clinical scoring. Nasal flaring 
is often used in diagnosis and in clinical scoring systems to determine the severity of 
heaves (Rush et al. 1998b; Couetil et al. 2001; Courouce-Malblanc et al. 2007), but in the 
current study nasal flaring was hardly noticeable and did not seem to be affected by the 
different treatments and therefore did not effect the total clinical scores.  There are 
several discrepancies between studies regarding the clinical signs used to determine the 
severity of heaves and a standardised, internationally accepted clinical scoring system for 
equine lower airway disease is required.  
Similar to observations of other investigators, I also did not find any alterations in 
hemograms of mares following induction of heaves (McPherson et al. 1978; Davis and 
Rush 2002), and following the GC treatments (Parbhakar et al. 2004).   
The clinical signs of heaves are due to bronchoconstriction and accumulation of 
mucus and neutrophils in the airways (Robinson et al. 1996; Robinson et al. 2003). 
Indeed, mares exposed to MH showed an increase in the total cell and neutrophil 
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concentrations in the BALF. Depletion of PIMs reduced the neutrophil concentration to 
the control levels. It is well documented that activation of PIMs by intravascular LPS 
enhances the migration of neutrophils into the lung (Warner 1996; Singh et al. 2004; 
Parbhakar et al. 2005). However, this is the first study of the effect of inhaled endotoxin 
as well as other irritating molecules on the equine PIMs that are embedded in lung 
vascular endothelium. The results of this study indicate a potential role of the PIMs in the 
development of an airborne pathology. The PIMs are located on the vascular side of the 
air-blood barrier, thus their involvement in an airborne pathology is intriguing. One 
explanation for such involvement of PIMs could be transport of an airborne pathogen or 
infectious agent across the blood-air barrier, either through transcellular routes across an 
intact barrier or following physical disruption of the barrier leading to their interaction 
with PIMs. It was previously shown in cattle that intratracheally instilled M. hemolytica 
leukotoxin was detected in PIMs which suggests leukotoxin transfer across the blood-air 
barrier (Whiteley et al. 1990).  The TLR4 expressed in equine PIMs will enable them to 
respond to endotoxin transported across the blood-air barrier (Singh Suri et al. 2006). 
Another explanation is that the inflammatory response generates circulating particulate 
debris and cells that are cleared by the PIMs which activates them with or without the 
transport of the infectious agents across the air-blood barrier (Warner 1996). It is also 
possible that inflammatory mediators produced by activated airway epithelium and 
alveolar macrophages in heaves horses may activate PIMs either following migration 
across the blood-air barrier or through production of an intermediary signalling molecule 
from the alveolar epithelium. Similar mechanisms have been reported in rats following 
instillation of TNFα in the alveoli (Kuebler et al. 2000). Although the mechanism 
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remains unclear, the data presented here showing reduced lung inflammation in GC-
treated horses indicate activation of PIMs and their pro-inflammatory role in heaves. 
The mode by which the depletion of PIMs reduces the neutrophil concentration in 
the alveolar space of horses with heaves can be explained in several ways. PIMs were 
shown to contain TLR4 and to be the major source of TLR4 in the lungs of horses (Singh 
Suri et al. 2006). Hence, LPS-LBP-CD14 complex associates with TLR4 and results in 
activation of the PIMs. Consequently, these activated PIMs secrete pro-inflammatory 
mediators (Parbhakar et al. 2005) that promote pulmonary recruitment of neutrophils. In 
addition, the increase in neutrophil concentration in the alveolar space of horses with 
heaves is believed not only to be due to increased migration of these cells, but also to the 
delay in their apoptosis. This enhanced neutrophils survival is induced, among others,  by 
granulocyte/macrophage colony stimulating factor (GM-CSF) (Turlej et al. 2001).  
The significant increase in TLR4 mRNA when mares were fed with MH can 
imply either that TLR4 expression is increased or that the proportion of cells expressing 
TLR4 has increased in the BALF. Regardless of the mechanism, the increase in TLR4, a 
crucial receptor of LPS (Aderem and Ulevitch 2000; Baumgarten et al. 2006), marks the 
increase in an inflammatory response which at least in part is triggered by endotoxin in 
MH. This result is in agreement with work done by Berndt et al. which demonstrated an 
involvement of TLR4 in the pathogenesis of heaves by showing an increase in TLR4 
mRNA expression in bronchial epithelial cells from heaves horses exposed to stable dust. 
This increase in TLR4 mRNA correlated with IL-8 mRNA expression as well as with 
neutrophilic airway inflammation (Berndt et al. 2007).  
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In addition to the lung cells such as pulmonary epithelial cells (Monick et al. 
2003; Ainsworth et al. 2006), alveolar macrophages (Fernandez et al. 2004; Singh Suri et 
al. 2006), endothelial cells (Andonegui et al. 2003; Singh Suri et al. 2006), airway 
smooth muscle cells (Morris et al. 2005), and PIMs (Singh Suri et al. 2006) that contain 
TLR4 on their surface, neutrophils were also shown to express this receptor (Sabroe et al. 
2002; Marsik et al. 2003). Activation of TLR4 on neutrophils causes changes in adhesion 
molecules expression, respiratory burst and IL-8 generation. Furthermore, the prolonged 
neutrophil survival which is a central component of their responses to pathogens, and as 
mentioned previously occurs in BAL neutrophils of heaves horses, was shown to require 
both TLR4 activation and the presence of monocytes which upon TLR4 activation release 
survival factors (Sabroe et al. 2003). The fact that GC treatment reduced the TLR4 
expression in BALF cells almost back to the control (Cb) implies that the depletion of 
PIMs not only inhibits the number of inflammatory cells that migrate to the airspace but 
also lowers the susceptibility of cells that do migrate to the alveolar space to LPS and 
consequently lowers the inflammatory response.  
 
6.3. Depletion of PIMs protects against a second endotoxin challenge 
Horses with severe airway obstruction may develop secondary bacterial infection, 
due to lower clearance capability (Davis and Rush 2002), although once the secondary 
pathogen enters the small airways it may be eliminated faster due to increased number of 
activated inflammatory cells in the airways and an increased inflammatory response. 
Other than the possible opportunistic infections that may occur, the ongoing exposure to 
dust and endotoxin in the dust in horses with heaves ultimately generates an exaggerated 
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inflammatory response leading to worse clinical signs and prognosis of the horse. Hence, 
I raised the question whether cells recovered from BALF of horses with heaves behave 
differently to a second LPS challenge when mares were pre-treated with GC. Although 
the mRNA expression levels of the 6 h media exposure are equivalent to the results in the 
previous section, the statistical significances may be different than reported in the earlier 
section since more values were included in current statistical analysis (i.e. combined 
analysis on both LPS and no-LPS results vs. analysis only on the non-LPS results).  
It was previously shown that a strong chemotactic activity in the BALF is 
associated with high levels of dust exposure and that in vitro stimulated alveolar 
macrophages have impaired phagocytotic efficiency but become specialized in secretion 
of neutrophils chemo-attractants such as IL-8 and macrophage inflammatory protein-2 
(MIP-2) (Franchini et al. 1998). In the study presented here, a significant increase in the 
IL-8 mRNA expression was demonstrated in cells isolated from mares after MH 
exposure. This increase was more pronounced after challenging the cells with a “second 
in vitro hit” with LPS. The IL-8 mRNA expression decreased almost back to the control 
levels (Cb) in cells isolated from mares exposed to MH and treated with GC. In addition, 
cells recovered from mares that were exposed to MH and treated with GC did not react to 
the second LPS hit, or reacted similar to the cells recovered from the control environment 
(Cb). Hence, it appears that depletion of PIMs by GC either inhibits the expression of 
chemotactic factors by inflammatory cells that reside in the bronchoalveolar space, or 
inhibits the migration of cells responsible to such chemotactic activity, leaving only the 
inactivated resident cells in the bronchoalveolar space. Nevertheless, the results presented 
here are in agreement with other studies which showed that an ongoing exposure to LPS 
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such as often occurs in heaves, or a secondary bacterial infection in heaves horses, causes 
an increase in the chemotactic activity in the bronchoalveolar space (Franchini et al. 
1998). This chemotaxis may be reduced to the control levels by depletion of the PIMs 
which will eliminate a major source of proinflammatory cytokines. These 
proinflammatory signals normally activate inflammatory cells in the airways or activate 
endothelium and inflammatory cells in the vasculature to migrate to the airway and 
continue to produce pro-inflammatory chemokines and cytokines.  
As opposed to IL-8, TLR4 mRNA expression did not seem to be affected by the 
second in vitro LPS challenge. It was previously shown that both the dose of LPS as well 
as the length of exposure determines the level of TLR4 expression in macrophages cells 
lines. A high dose of LPS (100 ng/ml) for 2.5 h severely reduced the mRNA expression 
of TLR4; however, the expression returned to the original level after a 20 h stimulation. 
In addition, TLR4 mRNA expression level at 24 h of LPS treatment was almost at the 
same level as that of non-treated cells (Nomura et al. 2000).  The LPS dose used in the 
current study was 1 μg/ml; a dose higher than the “high dose” of the above cited report. 
Hence, it is possible that an overstimulation of the cells in this study initially caused a 
shutdown or down-regulation in the TLR4 expression and after 6 h exposure to LPS the 
TLR4 expression was restored back to its original levels (i.e. without the LPS).  
TNFα protein was not detected in the supernatant collected immediately after the 
BAL procedure. This is probably due to the high volumes of lavage fluid used (1 liter for 
each horse), which exceedingly diluted the sample. Inconsistencies between the TNFα 
protein concentrations and the mRNA expression levels after incubation of the cells were 
found. The cause of the inconsistencies is not apparent from the results. In addition the 
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results did not show any consistent or meaningful effect of the different treatments (i.e. 
mouldy hay, cubes and gadolinium chloride) on the TNFα expression. However, a 
significant increase in the TNFα protein and mRNA expression was induced by a second 
in vitro LPS exposure. These results are not consistent with a previous report which 
indicated an increase in the TNFα mRNA in BALF of horses with heaves after exposure 
to MH (Giguere et al. 2002). Nevertheless, most of the investigations concerning 
cytokine production in horses with heaves concentrated on the question whether the 
response is predominately Th2 (i.e. IL4 and IL5) or Th1 (i.e. INF-γ) and no consistent 
findings on cytokine mRNA expressions were found between studies (Giguere et al. 
2002; Cordeau et al. 2004; Horohov et al. 2005).  These disparate results were suggested 
to be the result of differences in the clinical stage of the affected animals or the timing of 
sample collection. Horses in the earliest stage of heaves are likely to exhibit a classic 
Type 2 cytokine response to the allergen but prolonged exposure to the allergen induces a 
chronic phase characterised by increased production of IL-8 and IFN- γ with subsequent 
airway remodelling (Horohov et al. 2005). TNFα is an acute phase cytokine and it is 
possible that lack of differences for this cytokine among groups may be due the stage of 
disease in the experimental animals. However, a second hit with LPS initiated an acute 
response marked by a significant increase in the protein and mRNA levels of TNFα 
indicating that cells were capable of producing the cytokine and that my results were not 
due to any technical issues. 
 In order to minimize irritation during the BAL procedure which may lead to 
coughing and consequently damage the bronchi, 2% lidocaine HCl was injected to the 
airways while passing the endoscope. The anti-inflammatory effect attributed to lidocaine 
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(Kawasaki et al. 2006; Feng et al. 2008) could have affected the results observed in cells 
retrieved from the MH challenge as well as the second in-vitro LPS challenge. Since the 
amount used in this study (20 ml) was greatly diluted with the 500 ml of saline used to 
flush each side of the lung, and since the same procedure was carried out in all the BALs 
performed in all the mares, the effect of lidocaine is most likely minor in this study. 
The data from the horse experiments are novel since they identify the PIMs as 
important cells involved in the development of lung pathology such as heaves, which is 
induced by inhaled irritants. Following exposure to the dust and endotoxin in the MH 
environment the mares developed clinical signs suggestive of heaves as well as increased 
concentration of total bronchoalveolar cells, mainly neutrophils. This increase in 
neutrophil concentration in the bronchoalveolar space coincides with the increase in 
neutrophil chemoattractant (IL-8) and LPS recognition receptor (TLR4). I suggest a pro-
inflammatory affect of the PIMs, since after their depletion the clinical development as 
well as the accumulation of inflammatory cells and pro-inflammatory molecules subside. 
The depletion of the PIMs not only protected from the development of heaves but also 
from an exaggerated inflammatory response following a second challenge with LPS. 
Figure 6.1 outlines the major findings of this study. 
 
6.4. PIMs in human lungs 
There is a controversy surrounding the occurrence of PIMs in human. Dehring 
and Wismar (Zeltner et al. 1987; Dehring and Wismar 1989) showed large mononuclear 
cells with phagocytic vacuoles in clinical human lung biopsy specimens, but 
morphometric studies of normal human lungs have not described macrophages or 
64 
 
unusually large mononuclear cells in pulmonary capillaries (Gehr et al. 1978; Zeltner et 
al. 1987). The accepted notion today is that the normal human lung does not appear to 
have a large population of phagocytically active mature macrophages in pulmonary 
capillaries. However, it is known that rats can recruit PIMs under physiological stress 
induced with sepsis (Charavaryamath et al. 2006) or liver damage (Chang and Ohara 
1994). Based on the data obtained from the horses on the role of PIMs in an airborne non-
infectious lung pathology, I decided to examine whether there is recruitment of PIMs in 
lungs of humans suffering from COPD or asthma.  
Equine heaves resembles several human pulmonary diseases, mostly asthma but 
also COPD, both in the pathogenesis of the diseases and in the contribution of endotoxin 
to the development and exacerbation of the diseases. Inhaled endotoxins are an important 
cause of human COPD (Rushton 2007), with the severity of pulmonary inflammation and 
clinical symptoms experienced by subjects exposed to organic dusts being related to the 
endotoxin concentration of the inhaled dust (Rylander and Bergstrom 1993; Smid et al. 
1994; Iversen et al. 2000; Kirychuk et al. 2006). In addition, the severity of human 
asthma has also been related to the level of endotoxin exposure, suggesting that inhaled 
endotoxin may potentiate the inflammatory response to allergens in atopic subjects 
(Michel et al. 1996; Rizzo et al. 1997). If indeed humans recruit PIMs under these 
pathological conditions, depletion of these cells, similar to the horses, might ameliorate 
the clinical development of these diseases.  
The immunhistology results on the number of pulmonary septal macrophages did 
not reveal a significant difference in humans COPD/asthmatic patients as compared to the 
control patients. Surprisingly, there was a tendency (P = 0.1) of lower number of septal 
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macrophages in the diseased patients than in the control, which suggests occurrence of 
higher numbers of PIMs in lungs from humans who died because of non-pulmonary 
causes.  The cause for these unexpected findings cannot be determined. Because precise 
identification of PIMs can only be done using electron microscopy, immunohistology in 
this experiment detected septal macrophages which may represent the PIMs but also the 
macrophages in the interstitium or in the process of migration into the alveolar space. In 
addition, a reduction in alveolar macrophage numbers occurs following LPS inhalation in 
other species, possibly due to LPS-induced macrophage apoptosis (Bingisser et al. 1996; 
Pirie et al. 2001). Similar mechanisms may induce apoptosis in PIMs following long term 
exposure to LPS. However, this does not explain the fact that the non-diseased patients 
had a tendency of higher septal macrophage counts considering that under normal 
conditions human lungs are believed to be devoid of PIMs. The loss of normal pulmonary 
septal structures and fibrotic changes observed in hematoxylin and eosin stained sections 
from COPD/asthmatic patients indicates an exceedingly chronic process with no apparent 
inflammation. This can explain the low number of septal macrophages in some sections 
from diseased patients. In addition, the marked inflammation, edema and pulmonary 
haemorrhage observed in sections from control patients may explain the high number of 
septal macrophages in these sections. These observations may benefit from an increase in 
the sample size both from the COPD/asthmatic patients as well as from the control 
patients. The data obtained here might indicate, as opposed to previous reports, the 
occurrence of PIMs in normal human lung.  
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Figure 6.1. Outline of the major findings  
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7. SUMMARY 
The first objective was to determine whether PIMs are involved in the clinical 
development of heaves in horses. The depletion of the PIMs when mares were fed with 
MH reduced the neutrophil concentration in the bronchoalveolar space and consequently 
reduced the development of clinical signs almost back to the control levels (cubes). This 
suggests an active role of the PIMs in the enhancement of heaves.   
In order to better understand the involvement of PIMs in the pathogenesis of 
heaves, I examined the effect of PIM depletion on the activation state of BAL cells by 
determining the levels of three distinct pro-inflammatory molecules: TLR4 – a crucial 
receptor in the recognition of LPS; IL-8 – a neutrophilic chemoattractant; and TNFα – an 
acute phase pro-inflammatory cytokine. Interleukin-8 and TLR4 mRNA levels were both 
significantly decreased in BAL cells isolated from mares challenged with MH that 
received the GC treatment. The reduction in mRNA of these two pro-inflammatory 
molecules indicates an attenuation of BAL cell activation. In addition, consistent with the 
reduction of IL-8 mRNA expression fewer neutrophils had migrated to the 
bronchoavleolar space, and the reduction in the TLR4 mRNA expression would have 
lowered the susceptibility of the inflammatory cells to LPS and hence lowered the overall 
inflammatory response. Since mares in this study were susceptible to heaves and the BAL 
was performed after 7 days of MH exposure, the mares were probably at a later clinical 
stage and hence the TNFα, which is an acute phase pro-inflammatory cytokine, was not 
affected by the treatments. I also wanted to determine the effect of PIM depletion on a 
second in vitro challenge with LPS, which represents both an ongoing exposure to the 
endotoxin in the dust and a second challenge in heaves horses. The LPS in vitro challenge 
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was performed on BAL cells isolated from mares that underwent the different treatments 
(Cb, Cb-GC, MH, MH-GC). While the TNFα results were not conclusive, the second 
LPS challenge significantly increased the IL-8 mRNA expression in cells isolated from 
mares exposed to MH but not from mares exposed to MH and treated with GC. TLR4 did 
not seem to be affected by the second LPS challenge. However, similar to the IL-8 
mRNA expression, in both LPS- and non-LPS-treated cells the TLR4 mRNA expression 
was lower in mares exposed to MH after treatment with GC as compared to the non-
treated mares.   Hence, depletion of PIMs reduced the activation state as well as the 
susceptibility of bronchoalveolar cells to a second challenge with LPS.  
Lastly, I found a trend for reduced numbers of septal macrophages in lungs from 
humans suffering from non-infectious pulmonary diseases such as COPD or asthma 
compared to those who died due to non-pulmonary complications. If these septal 
macrophages are indeed PIMs, this finding is interesting as it indirectly indicates 
presence of PIMs in normal human lungs which is a controversial topic. These 
preliminary observations need to be expanded through an expanded sample size as well 
as additional techniques such as electron microscopy.  
The following diagram summarizes the suggested involvement of PIMs in the 
development of an airborne pathology. 
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Figure 7.1. The suggested involvement of PIMs in the development of an airborne 
pathology. Inhaled dust and LPS activates the alveolar macrophages (AM) and the 
epithelial lining of the alveolar space. These activated cells produce proinflammatory 
mediators (i.e. TNFa, IL-1β, IL-8) which activate the PIMs and the endothelial cells to 
express adhesion molecules. LPS may also penetrate the vasculature though an injured 
blood-air barrier, bind to the CD14-TLR4 complex and further activate the PIMs. 
Activated PIMs produce inflammatory mediators which activate both circulating 
neutrophils as well as the endothelium. Activated neutrophils express high levels of 
TLR4, adhere to the endothelium and start migrating towards a chemotactic gradient into 
the alveolar space. At this stage there are high number of activated inflammatory cells in 
the alveolar space, due to the increase in the TLR4 expression these cells are more 
responsive to the inhaled LPS, which reactivates them, and they further contribute to the 
ongoing inflammatory process.  
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8. CONCLUSIONS 
 
Gadolinium chloride treatment: 
a. attenuates the development of clinical signs of heaves 
b. attenuates the migration of inflammatory cells, especially of neutrophils to the 
alveolar space in the development of heaves 
c. decreases the activation state of BAL cells, marked by a decrease in TLR4 and 
IL-8 mRNA, in the development of heaves 
d. and reduces the activation of bronchoalveolar cells and their susceptibility to LPS. 
Based on the data and above conclusions, the hypothesis that the depletion of 
PIMs in horses will attenuate the activation of airway inflammatory cells and reduce 
proinflammatory cytokines production in the development of heaves and in consequence 
will attenuate clinical signs of heaves and lower the response of BAL cells to a secondary 
challenge with LPS appears to be correct. Hence, PIMs play a major pro-inflammatory 
role in the development of an airborne pathology such as heaves in horses.  
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9.  PROPOSED FUTURE RESEARCH 
To further understand the role of PIMs in the pathogenesis of heaves, rather than 
in the development of heaves, and whether resident PIMs have a different role than 
recruited PIMs, it is important to pursue the clinical, cellular and molecular effects of the 
depletion of PIMs that have already been activated. Investigating the effect of alveolar 
macrophage depletion on the development of heaves will enhance our understanding on 
the role of alveolar macrophages in animals containing PIMs, the crosstalk between AM 
and PIMs, and whether AM function differently in animals containing PIMs than animals 
that are devoid of them. It would also be interesting to pursue the question of whether 
airborne LPS activates the PIMs directly or though secondary signalling molecules. 
Localization of LPS in the PIMs after airway exposure will indicate a direct activation of 
the PIMs by inhaled endotoxin. Lastly, the similarities between equine heaves and certain 
human pulmonary pathologies require further investigation on whether humans recruit 
PIMs under certain pathologic conditions. If indeed human recruit these specialized cells, 
studying their role in equine heaves can shed some light on the effect of PIMs in the 
development of such pathologies in human patients.  
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